Average Co-Inventor Count = 2.59
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (19 from 1,975 patents)
2. The General Hospital Corporation (1 from 2,893 patents)
19 patents:
1. 8258262 - N-terminally chemically modified protein compositions and methods
2. 8143380 - Therapeutic peptides
3. 7662933 - N-terminally chemically modified protein compositions and methods
4. 7262166 - Chemically modified novel erythropoietin stimulating protein compositions and methods
5. 7160924 - Protein conjugates with a water-soluble biocompatible, biodegradable polymer
6. 6956027 - N-terminally chemically modified protein compositions and methods
7. 6770746 - Chemical modification of proteins to improve biocompatibility and bioactivity
8. 6586398 - Chemically modified novel erythropoietin stimulating protein compositions and methods
9. 6420340 - Chemical modification of proteins to improve biocompatibility and bioactivity
10. 6420339 - Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
11. 6204247 - Chemical modification of proteins to improve biocompatibility and bioactivity
12. 6017876 - Chemical modification of granulocyte-colony stimulating factor (G-CSF)
13. 5985265 - N-terminally chemically modified protein compositions and methods
14. 5900404 - Chemical modification of proteins to improve biocompatibility and
15. 5824784 - N-terminally chemically modified protein compositions and methods